Global distribution of treatment resistance gene markers for leishmaniasis

S Salari, M Bamorovat, I Sharifi… - Journal of Clinical …, 2022 - Wiley Online Library
Abstract Background Pentavalent antimonials (Sb (V)) such as meglumine antimoniate
(Glucantime®) and sodium stibogluconate (Pentostam®) are used as first‐line treatments for …

Thiol redox biology of trypanosomatids and potential targets for chemotherapy

AE Leroux, RL Krauth-Siegel - Molecular and Biochemical Parasitology, 2016 - Elsevier
Trypanosomatids are the causative agents of African slee** sickness, Chagas' disease,
and the different forms of leishmaniasis. This family of protozoan parasite possesses a …

[HTML][HTML] Recent advances on the piezoelectric, electrochemical, and optical biosensors for the detection of protozoan pathogens

M Feyziazar, M Amini, A Jahanban-Esfahlan… - TrAC Trends in …, 2022 - Elsevier
The important protozoan parasites including Plasmodium, Leishmania, Toxoplasma,
Trypanosoma and Giardia have been proved as the main reason initiating and develo** …

[HTML][HTML] Computational approaches for drug discovery

S Brogi - Molecules, 2019 - mdpi.com
Computational approaches represent valuable and essential tools in each step of the drug
discovery and development trajectory. Several computational methodologies are suitable to …

Recent progress in drug targets and inhibitors towards combating leishmaniasis

S Vijayakumar, P Das - Acta tropica, 2018 - Elsevier
Lesihmaniasis is one of the major neglected tropical disease caused by the parasite of the
genus Leishmania. The disease has more than one clinical forms and the visceral form is …

Polyamine-trypanothione pathway: an update

A Ilari, A Fiorillo, I Genovese… - Future Medicinal Chemistry, 2017 - Taylor & Francis
In trypanosomatids, polyamine and trypanothione pathways can be considered as a whole
unique metabolism, where most enzymes are essential for parasitic survival and infectivity …

Current therapeutics, their problems and thiol metabolism as potential drug targets in leishmaniasis

K Singh, G Garg, V Ali - Current drug metabolism, 2016 - ingentaconnect.com
Leishmaniasis is one of the six diseases regarded most neglected by World Health
Organization which is predominant in develo** countries. Clinically, among the different …

Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening

L Turcano, E Torrente, A Missineo… - PLoS Neglected …, 2018 - journals.plos.org
Trypanothione reductase (TR) is considered to be one of the best targets to find new drugs
against Leishmaniasis. This enzyme is fundamental for parasite survival in the host since it …

Integrated virtual screening and molecular dynamics simulation revealed promising drug candidates of p53-MDM2 interaction

AQK Oyedele, TI Adelusi, AT Ogunlana… - Journal of Molecular …, 2022 - Springer
In the vast majority of malignancies, the p53 tumor suppressor pathway is compromised. In
some cancer cells, high levels of MDM2 polyubiquitinate p53 and mark it for destruction …

Dietary polyphenols rutin, taxifolin and quercetin related compounds target Leishmania amazonensis arginase

ER da Silva, S Brogi, JF Lucon-Júnior, G Campiani… - Food & function, 2019 - pubs.rsc.org
Quercetin related compounds were tested against Leishmania amazonensis arginase, a
potential target for the development of new approaches in treating leishmaniasis. The IC50 …